Pulmonary hypertension
Our updated and revised pulmonary arterial hypertension programme contains four modules designed to cover all aspects of the condition, from its classification and pathology through to the latest advances in diagnosis and treatment. Its five hours of interactive learning – endorsed by PHA Europe – leads to five continuing professional development (CPD) credits.
The programme was originally made available with an educational grant from Pfizer, and independently written by leading UK experts. The original programme was revised by BJC Learning in 2016.
Dr Simon Gibbs, Clinical Senior Lecturer in Cardiology, National Heart and Lung Institute, Imperial College London
Dr Shareen Jaijee, Honorary Consultant Cardiologist, Imperial College Healthcare Trust, Clinical Research Fellow, Imperial College
Dr Rachel Arthur, British Journal of Cardiology, London
Dr Rachel Davies, Consultant Chest Physician, Hammersmith Hospital, London
Dr Luke Howard, Consultant Chest Physician, Hammersmith Hospital, London
Mr David Jenkins, Consultant Cardiothoracic Surgeon, Papworth Hospital, Cambridge
Dr Henry Oluwasefunmi Savage, Specialist Registrar in Cardiology, Imperial College Healthcare Trust, Clinical Research Fellow, Imperial College
Pulmonary hypertension module 1: introduction, classification, pathology
Released 2 December 2016 Programme: Pulmonary hypertension 1 CPD/CME credit
- Recognise when to refer patients to a PAH centre
- Understand the pathophysiology of PAH
- Know the functional classification of pulmonary hypertension
- Understand screening for pulmonary hypertension
Pulmonary hypertension module 2: presentation and investigation
Released 2 December 2016 Programme: Pulmonary hypertension 2 CPD/CME credits
- Describe the clinical presentation of PAH in adults
- Review investigations for PAH
- Understand the prognosis of patients with PAH
Pulmonary hypertension module 3: treatment
Released 2 December 2016 Programme: Pulmonary hypertension 2 CPD/CME credits
- Understand general measures in treating PAH
- Know background medical therapy in PAH
- Understand drug-drug interactions
- Recognise causes of deterioration in patients with PAH
Pulmonary hypertension module 4: special groups
Released 2 December 2016 Programme: Pulmonary hypertension 0.5 CPD/CME credits
- Understand the association between PAH and congenital heart disease
- Understand the association between PAH and connective tissue diseases
- Review patient support groups for pulmonary hypertension in the UK
